Imugene Ltd
ASX:IMU
Prices of ASX stocks are not being updated. The latest IMU price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Imugene Ltd (IMU) under the Base Case is AUD per share.
Compared with the last price of 0.036 AUD on Oct 14, the stock appears .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Our estimate of what one share is worth.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Imugene Does
Imugene Ltd is a biotechnology company that develops cancer immunotherapy drugs. Its main work is to design and test treatments that help the body’s immune system recognize and attack cancer cells. The company does not sell a broad portfolio of medicines; instead, it focuses on a pipeline of experimental therapies that are still in development and clinical testing.
- Headquarters
- Australia AU
- IPO date
- Dec 2, 1993
Earnings Waterfall
Imugene Ltd
What is the Intrinsic Value of one IMU stock?
The intrinsic value for Imugene Ltd (IMU) under the Base Case is AUD.
Is IMU stock undervalued or overvalued?
Compared with the last price of 0.036 AUD on Oct 14, the stock appears .
